In breast cancer, colorectal cancer, and prostate cancer cells, PRMT4, PRMT5, and PRMT7 and their mediated hnRNPA1 methylation and splicing isomerism can effectively promote the growth of cancer cells. Here, PRMT5 is linked to prostate carcinoma.